Dr Lal PathLabs is eyeing to attain around 18% growth in its top-line in FY17 as it undertakes initiatives to expand number of tests offered and its network across India. The company would be adding 15 labs and around 200 collection centres, which are mainly franchise outlets during the fiscal year. Moreover, the company is likely to invest around Rs 40 crore for the same.
The company is also planning to expand in to South and West India. In south and west it has selected two cities Bengaluru and Pune. In these cities, it will develop critical mass and then expand.
Dr LalPath Labs has 172 clinical labs and one central laboratory, over 1,500 collection centres and 4,967 pick-up points. It currently conducts nearly 2,000 tests. The company had posted a revenue of Rs 791.3 crore for the fiscal year 2015-16.
| Company Name | CMP |
|---|---|
| Apollo Hospital Ent. | 7699.05 |
| Max Healthcare Inst | 1006.90 |
| Narayana Hrudayalay | 1825.55 |
| Aster DM Healthcare | 688.30 |
| Global Health | 1089.55 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: